156 related articles for article (PubMed ID: 23992341)
1. PET radiotracers for molecular imaging of serotonin 5-HT1A receptors.
Billard T; Le Bars D; Zimmer L
Curr Med Chem; 2014; 21(1):70-81. PubMed ID: 23992341
[TBL] [Abstract][Full Text] [Related]
2. PET tracers for 5-HT(1A) receptors and uses thereof.
Kumar JS; Mann JJ
Drug Discov Today; 2007 Sep; 12(17-18):748-56. PubMed ID: 17826688
[TBL] [Abstract][Full Text] [Related]
3. Agonist and antagonist bind differently to 5-HT1A receptors during Alzheimer's disease: A post-mortem study with PET radiopharmaceuticals.
Vidal B; Sebti J; Verdurand M; Fieux S; Billard T; Streichenberger N; Troakes C; Newman-Tancredi A; Zimmer L
Neuropharmacology; 2016 Oct; 109():88-95. PubMed ID: 27183968
[TBL] [Abstract][Full Text] [Related]
4. [18F]MPPF as a tool for the in vivo imaging of 5-HT1A receptors in animal and human brain.
Aznavour N; Zimmer L
Neuropharmacology; 2007 Mar; 52(3):695-707. PubMed ID: 17101155
[TBL] [Abstract][Full Text] [Related]
5. In vivo biased agonism at 5-HT
Vidal B; Fieux S; Redouté J; Villien M; Bonnefoi F; Le Bars D; Newman-Tancredi A; Costes N; Zimmer L
Neuropsychopharmacology; 2018 Oct; 43(11):2310-2319. PubMed ID: 30030540
[TBL] [Abstract][Full Text] [Related]
6.
Vidal B; Fieux S; Colom M; Billard T; Bouillot C; Barret O; Constantinescu C; Tamagnan G; Newman-Tancredi A; Zimmer L
Brain Struct Funct; 2018 Jul; 223(6):2973-2988. PubMed ID: 29730825
[TBL] [Abstract][Full Text] [Related]
7. Marmoset Serotonin 5-HT1A Receptor Mapping with a Biased Agonist PET Probe 18F-F13714: Comparison with an Antagonist Tracer 18F-MPPF in Awake and Anesthetized States.
Yokoyama C; Mawatari A; Kawasaki A; Takeda C; Onoe K; Doi H; Newman-Tancredi A; Zimmer L; Onoe H
Int J Neuropsychopharmacol; 2016 Dec; 19(12):. PubMed ID: 27608810
[TBL] [Abstract][Full Text] [Related]
8. Molecular imaging of the serotonin 5-HT7 receptors: from autoradiography to positron emission tomography.
Zimmer L; Billard T
Rev Neurosci; 2014; 25(3):357-65. PubMed ID: 24497222
[TBL] [Abstract][Full Text] [Related]
9. Radiosynthesis and preclinical evaluation of 18F-F13714 as a fluorinated 5-HT1A receptor agonist radioligand for PET neuroimaging.
Lemoine L; Becker G; Vacher B; Billard T; Lancelot S; Newman-Tancredi A; Zimmer L
J Nucl Med; 2012 Jun; 53(6):969-76. PubMed ID: 22577236
[TBL] [Abstract][Full Text] [Related]
10. A postmortem study to compare agonist and antagonist 5-HT1A receptor-binding sites in Alzheimer's disease.
Becker G; Streichenberger N; Billard T; Newman-Tancredi A; Zimmer L
CNS Neurosci Ther; 2014 Oct; 20(10):930-4. PubMed ID: 25041947
[TBL] [Abstract][Full Text] [Related]
11. In vitro assessment of the agonist properties of the novel 5-HT1A receptor ligand, CUMI-101 (MMP), in rat brain tissue.
Hendry N; Christie I; Rabiner EA; Laruelle M; Watson J
Nucl Med Biol; 2011 Feb; 38(2):273-7. PubMed ID: 21315283
[TBL] [Abstract][Full Text] [Related]
12. First-in-human evaluation of 18F-mefway, a PET radioligand specific to serotonin-1A receptors.
Hillmer AT; Wooten DW; Bajwa AK; Higgins AT; Lao PJ; Betthauser TJ; Barnhart TE; Rowley HA; Stone CK; Johnson SC; Mukherjee J; Christian BT
J Nucl Med; 2014 Dec; 55(12):1973-9. PubMed ID: 25453045
[TBL] [Abstract][Full Text] [Related]
13. Review of antidepressants in clinic and active ingredients of traditional Chinese medicine targeting 5-HT1A receptors.
Wang L; Zhang Y; Du X; Ding T; Gong W; Liu F
Biomed Pharmacother; 2019 Dec; 120():109408. PubMed ID: 31541883
[TBL] [Abstract][Full Text] [Related]
14. Altered brain serotonin 5-HT1A receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [carbonyl11C]WAY-100635.
Bailer UF; Frank GK; Henry SE; Price JC; Meltzer CC; Weissfeld L; Mathis CA; Drevets WC; Wagner A; Hoge J; Ziolko SK; McConaha CW; Kaye WH
Arch Gen Psychiatry; 2005 Sep; 62(9):1032-41. PubMed ID: 16143735
[TBL] [Abstract][Full Text] [Related]
15. In vivo occupancy of the 5-HT1A receptor by a novel pan 5-HT1(A/B/D) receptor antagonist, GSK588045, using positron emission tomography.
Comley RA; van der Aart J; Gulyás B; Garnier M; Iavarone L; Halldin C; Rabiner EA
Neuropharmacology; 2015 May; 92():44-8. PubMed ID: 25476970
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and initial evaluation of [11C](R)-RWAY in monkey-a new, simply labeled antagonist radioligand for imaging brain 5-HT1A receptors with PET.
McCarron JA; Zoghbi SS; Shetty HU; Vermeulen ES; Wikström HV; Ichise M; Yasuno F; Halldin C; Innis RB; Pike VW
Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1670-82. PubMed ID: 17579853
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, in vitro and in vivo evaluation of
Narayanaswami V; Tong J; Fiorino F; Severino B; Sparaco R; Magli E; Giordano F; Bloomfield PM; Prabhakaran J; Mann JJ; Vasdev N; Dahl K; Kumar JSD
EJNMMI Radiopharm Chem; 2020 May; 5(1):13. PubMed ID: 32430632
[TBL] [Abstract][Full Text] [Related]
18. Integrated Strategy for Use of Positron Emission Tomography in Nonhuman Primates to Confirm Multitarget Occupancy of Novel Psychotropic Drugs: An Example with AZD3676.
Varnäs K; Juréus A; Johnström P; Ahlgren C; Schött P; Schou M; Gruber S; Jerning E; Malmborg J; Halldin C; Afzelius L; Farde L
J Pharmacol Exp Ther; 2016 Sep; 358(3):464-71. PubMed ID: 27402278
[TBL] [Abstract][Full Text] [Related]
19. Current status of positron emission tomography radiotracers for serotonin receptors in humans.
Zimmer L; Le Bars D
J Labelled Comp Radiopharm; 2013; 56(3-4):105-13. PubMed ID: 24285316
[TBL] [Abstract][Full Text] [Related]
20. Comparison of 4 radiolabeled antagonists for serotonin 5-HT(7) receptor neuroimaging: toward the first PET radiotracer.
Lemoine L; Andries J; Le Bars D; Billard T; Zimmer L
J Nucl Med; 2011 Nov; 52(11):1811-8. PubMed ID: 21990574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
